On February 27, Saira Malik, Nuveen Chief Investment Officer, joined CNBC’s ‘Closing Bell Overtime’ to talk about what to expect from markets in the year to come. Malik identified four primary themes driving market volatility this year: trade, AI, the Middle East situation, and the future actions of central banks. Regarding the AI trade, she observed a notable shift within the tech sector from semiconductors to software, pointing out that software was previously under-owned in portfolios by ~100 to 150 basis points. This led to a recent rush of investors buying back into the sector.
Malik also provided a historical perspective on the political climate and noted that midterm election years typically experience high intra-year volatility, with markets declining an average of 18% at some point during such years. While this does not necessarily dictate where the market ends the year, she suggested that it indicates likely volatility ahead.
In midterm years where the Fed is not raising rates and the economy is growing, major downside outcomes are often avoided. In response, Malik shared Nuveen’s expectation that the Fed will likely cut rates twice in H2 of this year. She addressed the narrative surrounding Kevin Warsh, clarifying that she viewed him as a productivity bull rather than an inflation hawk. She explained his perspective as one where accelerating productivity keeps inflation at bay, while a weakening employment market provides the necessary room for rate cuts.
That being said, we’re here with a list of the 12 most promising micro-cap stocks according to analysts.
Our Methodology
We used screeners to identify stocks that are trading between $50 million and $300 million and have an average upside potential of at least 30%. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Note: All data was sourced on March 2.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
12 Most Promising Micro-Cap Stocks According to Analysts
12. Arqit Quantum Inc. (NASDAQ:ARQQ)
Arqit Quantum Inc. (NASDAQ:ARQQ) is one of the most promising micro-cap stocks according to analysts. On February 19, Arqit Quantum Inc. and 6WIND announced a partnership to launch integrated, quantum-safe VPN services tailored for telecommunications providers and enterprises. By combining Arqit’s NetworkSecure encryption key generation with 6WIND’s virtual service routers, the collaboration provides scalable security for site-to-site connectivity and cloud infrastructure.
These services are designed to run on universal customer premises equipment and virtualized environments, ensuring high availability and flexibility for B2B use cases. The joint solution addresses the growing threat of quantum computing to traditional public-key infrastructure and the immediate risk of ‘harvest now, decrypt later’ attacks.
By delivering an integrated, on-device IPsec solution, the companies aim to provide a new standard in cyber defense that protects critical data against both current and future cryptographic threats. This integration allows organizations to proactively secure their communications without compromising the performance or agility required by modern software-defined networks.
Arqit Quantum Inc. (NASDAQ:ARQQ) provides cybersecurity services through satellite and terrestrial platforms in the UK. It offers QuantumCloud, which is a Platform as a Service that creates unbreakable software encryption keys.
11. Prenetics Global Limited (NASDAQ:PRE)
Prenetics Global Limited (NASDAQ:PRE) is one of the most promising micro-cap stocks according to analysts. On February 18, Prenetics Global Limited reported financial results for 2025, headlined by a 480% year-over-year revenue surge to $92.4 million. This was fueled by the company’s flagship health and longevity brand, IM8, which reached an ARR of $120 million within just one year of its launch. The Q4 alone saw revenue reach of $36.6 million, a 55% increase over the previous quarter, reflecting the market traction of the brand co-founded by David Beckham.
The company completed a major strategic transformation by divesting non-core assets, including ACT Genomics, the Europa distribution business, and its stake in Insighta. These moves, including a $70 million cash sale of the Insighta stake to Tencent, have fortified the balance sheet with ~$171 million in adjusted liquidity and zero debt. Furthermore, Prenetics ceased all cryptocurrency purchases, maintaining a permanent holding of 510 BTC, as it pivots to become a pure-play leader in the consumer health and nutrition sector.
Looking ahead to 2026, Prenetics Global Limited (NASDAQ:PRE) reaffirmed its revenue guidance for IM8 at $180 to $200 million, aiming for an ARR of up to $300 million by year-end. A key driver for this anticipated growth is a shift toward quarterly subscription models, which has already increased the average order value to ~$233 in early 2026.
Prenetics Global Limited (NASDAQ:PRE) is a health sciences company that advances consumer health in Hong Kong, the US, and internationally. It sells health & wellness products under the IM8 brand name, and provides fulfillment & distribution services for sports nutrition products under the Europa brand.
